3988 Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Boehringer 

Ingelheim Chemical, Inc. 

ACTION: Notice of registration. 

SUMMARY: Boehringer Ingelheim 

Chemical, Inc. applied to be registered 

as a manufacturer of certain basic 

classes of controlled substances. The 

DEA grants Boehringer Ingelheim 

Chemical, Inc. registration as a 

manufacturer of the controlled 

substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated May 28, 2014, and published in 

the Federal Register on June 4, 2014, 79 

FR 32321, Boehringer Ingelheim 

Chemical, Inc., 2820 N. Normandy 

Drive, Petersburg, Virginia 23805–9372, 

applied to be registered as a 

manufacturer of certain basic classes of 

controlled substances. No comments or 

objections were submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Boehringer Ingelheim Chemical, Inc. to 

manufacture the basic classes of 

controlled substances is consistent with 

the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971. The DEA 

investigated the company’s maintenance 

of effective controls against diversion by 

inspecting and testing the company’s 

physical security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances: 

Controlled substance Schedule 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Methadone (9250) ........................ II 

Methadone Intermediate (9254) ... II 

The company plans to manufacture 

the listed controlled substances in bulk 

for sale to its customers for formulation 

into finished pharmaceuticals. In 

reference to methadone intermediate 

(9254) the company plans to produce 

methadone HCL active pharmaceutical 

ingredients (APIs) for sale to its 

customers. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01289 Filed 1–23–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: S & B 

Pharma, Inc. 

ACTION: Notice of registration. 

SUMMARY: S & B Pharma, Inc. applied to 

be registered as a manufacturer of 

certain basic classes of controlled 

substances. The DEA grants S & B 

Pharma, Inc. registration as a 

manufacturer of those controlled 

substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated July 1, 2014, and published in the 

Federal Register on July 8, 2014, 79 FR 

38564, S & B Pharma, Inc., DBA Norac 

Pharma, 405 South Motor Avenue, 

Azusa, California 91702–3232 applied 

to be registered as a manufacturer of 

certain basic classes of controlled 

substances. No comments or objections 

were submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of S & 

B Pharma, Inc. to manufacture the basic 

classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. The 

DEA investigated the company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing the company’s physical security 

systems, verifying the company’s 

compliance with state and local laws, 

and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed: 

Controlled 

Substance Schedule 

Gamma Hydroxybutyric Acid 

(2010).

I 

Tetrahydrocannabinols (7370) ..... I 

Methamphetamine (1105) ............ II 

Controlled 

Substance Schedule 

Pentobarbital (2270) ..................... II 

Nabilone (7379) ............................ II 

4-Anilino-N-phenethyl-4-piperidine 

(ANPP) (8333).

II 

Tapentadol (9780) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for use in product development and for 

commercial sales to its customers. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01287 Filed 1–23–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Research 

Triangle Institute 

ACTION: Notice of registration. 

SUMMARY: Research Triangle Institute 

applied to be registered as a 

manufacturer of certain basic classes of 

controlled substances. The DEA grants 

Research Triangle Institute registration 

as a manufacturer of those controlled 

substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated July 2, 2014, and published in the 

Federal Register on July 14, 2014, 79 FR 

40781, Research Triangle Institute, 

Kenneth S. Rehder, Ph.D., Hermann 

Building East Institute Drive, P.O. Box 

12194, Research Triangle Park, North 

Carolina 27709, applied to be registered 

as a manufacturer of certain basic 

classes of controlled substances. No 

comments or objections were submitted 

to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Research Triangle Institute to 

manufacture the basic classes of 

controlled substances is consistent with 

the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971. The DEA 

investigated the company’s maintenance 

of effective controls against diversion by 

inspecting and testing the company’s 

physical security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 


emcdonald on DSK67QTVN1PROD with NOTICES